×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Worldwide schedules comment Share

Online – Live Broadcast: Transpyrenean Oncogynae Symposium Day#2

Chaired by: Martina Ángeles & Véronique D’Hondt

Join us for a high-impact webinar dedicated to the latest advances in ovarian cancer management. This session will explore cutting-edge molecular insights, evolving surgical approaches, and real-world clinical applications.


PROGRAM OVERVIEW

09:30 - 09:50 | Opening Keynote

The French National Network for Rare Gynecologic Tumors: A Success Story
Isabelle Ray-Coquard
Lessons learned & impact on ovarian cancer treatment


SESSION 1: MOLECULAR LANDSCAPE & PERSONALIZED THERAPIES

09:50 - 10:20 | Moderators: Martina Ángeles & Véronique D’Hondt

Homologous Recombination Deficiency (HRD) Beyond BRCA1/2: A Molecular Journey
- French Perspective – Stanislas Quesada
- Spanish Perspective – Sonia Gatius

Interactive Q&A & Audience Polling

10:20 - 10:45 | Coffee Break & Virtual Exhibition Visit


SESSION 2: SURGICAL APPROACHES & EXPERT CENTERS

10:45 - 11:10 | FOCUS INNOVATION: Surgery for Ovarian Cancer

Expert Centers for Complex Surgeries: French & Spanish Perspectives
- French Perspective – Pierre-Emmanuel Colombo
- Spanish Perspective – Vicente Bebia
- Synthesis & Takeaways – Gwenaël Ferron

Live Q&A with Experts


SESSION 3: MULTIDISCIPLINARY CASE DISCUSSIONS

11:10 - 12:20 | Interactive Tumor Board: Optimal Medico-Surgical Strategies for 1L Treatment

Complex Case Discussions with a Multidisciplinary Panel
- MRI/CT-Scan Analysis – Stéphanie Nougaret
- Pathology & Biomarker Interpretation – Sonia Gatius
- 1L Maintenance Treatment for BRCAness Patients – David García Illescas
- 1L Maintenance Treatment for HRP Patients – Laurence Gladieff
- CHIP & Hyperthermic Intraperitoneal Chemotherapy – Pierre-Emmanuel Colombo
- FIGO IV Disease: Surgical vs. Medical Approaches – Martina Ángeles
- Patient-Centered Care & Quality of Life – Frédéric Fiteni

Live Panel Discussion & Audience Engagement


12:20 - 12:30 | Closing Remarks & Key Takeaways

Summary by the Scientific Committee


 

Shooting date : 2025-03-22
Last update : 2025-03-25

Suggestions

Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

PARPi dans le cancer de l'ovaire en 1L

Données actuelles et perspectives pour la combinaison avec l’IO

Share
Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Scroll Up